Trial intelligence / Profile preview

PRP added to exercise therapy for chronic ankle sprain

IRCT20180205038619N3Phase 3Completed

Sponsor
Iran University of Medical Sciences
Start
Jul 2024
Countries
1
01

Overview

Phase 3, single-blind trial of platelet-rich plasma in Ankle sprain (2 arms), sponsored by Iran University of Medical Sciences. Primary endpoints: Pain severity, Foot and Ankle Ability Measure and 1 more. Started Jul 2024; status: completed.

02

Drugs

platelet-rich plasma
03

Conditions

Ankle sprain

Beyond the preview

Go deeper on IRCT20180205038619N3.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20180205038619N3.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call